GALVUS NOVARTIS PDF

Novartis’ Galvus (vildagliptin) is a member of a new class of oral antidiabetic agents known as dipeptidyl peptidase IV inhibitors (DPP-IV) inhibitors or ‘incretin . Galvus Approval Status. FDA Approved: No Brand name: Galvus Generic name: vildagliptin. Previous Name: LAF Company: Novartis Pharmaceuticals. Vildagliptin is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl The European Medicines Agency has also approved a combination of vildagliptin and metformin, vildagliptin/metformin (Eucreas by Novartis) as an oral.

Author: Jugore Arashigal
Country: Somalia
Language: English (Spanish)
Genre: Medical
Published (Last): 22 November 2011
Pages: 149
PDF File Size: 1.54 Mb
ePub File Size: 19.17 Mb
ISBN: 215-9-97175-653-9
Downloads: 44518
Price: Free* [*Free Regsitration Required]
Uploader: Zulmaran

DPP-4 inhibition by vildagliptin is not affected by gender. Marketing authorisation number s 9. The novadtis can only be obtained with a prescription. Summary of the safety profile Safety data were obtained from a total of 3, patients exposed to vildagliptin at a daily dose of 50 mg once daily or mg 50 mg twice daily or mg once daily in controlled trials of at least 12 weeks duration. Norfloxacin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Norfloxacin.

Galvu therapeutic efficacy of Vildagliptin can be decreased when used in combination with Nelfinavir. By increasing levels of incretin hormones in the blood, vildagliptin stimulates the pancreas to produce more insulin when blood glucose levels are high. The risk or severity of angioedema can be increased when Vildagliptin is combined with Azilsartan medoxomil.

The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Fluticasone furoate. Noovartis, gastro-oesophageal reflux disease.

  ECCRINE HIDRADENOMA PDF

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) | European Medicines Agency

Furazolidone Furazolidone may increase the hypoglycemic activities of Vildagliptin. Ciprofloxacin The therapeutic efficacy of Vildagliptin can be increased when used in combination with Ciprofloxacin.

The risk or severity of hypoglycemia can be increased when Quinine is combined with Vildagliptin. The therapeutic efficacy of Vildagliptin can be increased when used in combination with Acetazolamide. The risk or severity of angioedema can be increased when Alteplase is combined with Vildagliptin.

The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Dexamethasone. The incidence of peripheral oedema was lower in the vildagliptin group gxlvus in the rosiglitazone group 2.

Galvus 50 mg Tablets

Gallopamil The risk or severity of hypoglycemia can be increased when Gallopamil is combined with Vildagliptin. Mebutizide The therapeutic efficacy of Vildagliptin can be increased when used in combination with Mebutizide.

The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Fludrocortisone. Pipotiazine The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Pipotiazine. A pre- and postnatal development study was performed in rats. Doxepin Doxepin may decrease the hypoglycemic activities of Vildagliptin. The risk or severity of hypoglycemia can be increased when Lercanidipine is combined with Vildagliptin.

To bookmark a medicine you must sign up and log in. The risk or severity of hypoglycemia can be increased when Phenformin is combined with Vildagliptin. A multiple-dose, open-label trial was conducted to evaluate the pharmacokinetics of the lower therapeutic dose of vildagliptin 50 mg once daily in patients with varying degrees of chronic renal impairment defined by creatinine clearance mild: Bepridil The risk or severity of hypoglycemia can be increased when Bepridil is combined with Vildagliptin.

  GAY ESCODA CIRUGIA BUCAL TOMO 2 PDF

The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Cyclopenthiazide. The risk or severity of hypoglycemia can be increased when Pramlintide is combined with Vildagliptin.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis)

This material is provided for educational purposes only and is not intended for galvuz advice, diagnosis or treatment. Acarbose The risk or severity of hypoglycemia can be increased when Acarbose is combined with Vildagliptin.

At mg, one subject experienced oedema of the feet and hands, and increases in creatine phosphokinase CPKaspartate aminotransferase ASTC-reactive protein CRP and myoglobin levels. Hypoglycaemia Sulphonylureas are known to cause hypoglycaemia.

The risk or severity of angioedema can be increased when Vildagliptin is combined with Evogliptin. Novvartis risk or severity of hypoglycemia can be increased when Lamotrigine is combined with Vildagliptin. Verapamil The risk or severity of hypoglycemia can be increased when Verapamil is combined with Vildagliptin. The therapeutic efficacy of Vildagliptin can be decreased when used in combination with Levonorgestrel. Last updated on eMC:

Author: admin